NCT02770872View on ClinicalTrials.gov

The Association of SAA With Apolipoprotein B Affects Cardiovascular Risk

CompletedOBSERVATIONAL
Enrollment

19

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

February 28, 2018

Study Completion Date

February 28, 2018

Conditions
Cardiovascular Disease
Interventions
OTHER

Observation of SAA on apoB containing lipoproteins

attempting to elicit the conditions by which SAA shifts from apo-A1 containing lipoproteins to apoB containing lipoproteins

Trial Locations (1)

40515

VA Medical Center, Lexington

All Listed Sponsors
collaborator

VA Office of Research and Development

FED

lead

Lisa Tannock

OTHER

NCT02770872 - The Association of SAA With Apolipoprotein B Affects Cardiovascular Risk | Biotech Hunter | Biotech Hunter